XML 63 R42.htm IDEA: XBRL DOCUMENT v3.21.4
FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2021
Dec. 31, 2020
Fair Value Disclosures [Abstract]    
SCHEDULE OF FINANCIAL INSTRUMENT MEASURED ON RECURRING BASIS

 SCHEDULE OF FINANCIAL INSTRUMENT MEASURED ON RECURRING BASIS

   As of September 30, 2021   Fair Value Measurements 
   Carrying   Fair   As of September 30, 2021 
   Amount   Value   Level 1   Level 2   Level 3 
          (unaudited)         
Liabilities:                    
Contingent consideration:                         
Asuragen (1)  $2,136   $2,136   $      -   $-   $2,136 
Other long-term liabilities:                         
Warrant liability (2)   158    158    -    -    158 
   $2,294   $2,294   $-   $-   $2,294 

 

   As of December 31, 2020   Fair Value Measurements 
   Carrying   Fair   As of December 31, 2020 
   Amount   Value   Level 1   Level 2   Level 3 
                     
Liabilities:                         
Contingent consideration:                         
Asuragen (1)  $2,216   $2,216   $-   $-   $2,216 
Other long-term liabilities:                         
Warrant liability (2)   21    21    -    -    21 
   $2,237   $2,237   $-   $-   $2,237 

 

(1)(2) See Note 9, Accrued Expenses and Long-Term Liabilities 

 

   As of December 31, 2020   Fair Value Measurements 
   Carrying   Fair   As of December 31, 2020 
   Amount   Value   Level 1   Level 2   Level 3 
                        
Liabilities:                         
Contingent consideration:                         
Asuragen (1)  $2,216   $2,216   $-   $     -   $2,216 
Other long-term liabilities:                         
Warrant liability (2)   21    21    -    -    21 
   $2,237   $2,237   $-   $-   $2,237 

 

   As of December 31, 2019   Fair Value Measurements 
   Carrying   Fair   As of December 31, 2019 
   Amount   Value   Level 1   Level 2   Level 3 
                     
Liabilities:                         
Contingent consideration:                         
Asuragen (1)  $2,893   $2,893   $   -   $   -   $2,893 
Other long-term liabilities:                         
Warrant liability (2)   82    82    -    -    82 
   $2,975   $2,975   $-   $-   $2,975 
SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION

A roll forward of the carrying value of the Contingent Consideration Liability and the 2017 Underwriters’ Warrants to September 30, 2021 is as follows:

 SCHEDULE OF FAIR VALUE, ASSETS MEASURED ON RECURRING BASIS, UNOBSERVABLE INPUT RECONCILIATION

              

Cancellation

of Obligation/

  

Adjustment

 to Fair Value/

     
   December 31, 2020   Payments   Accretion   Conversions Exercises   Mark to Market   September 30,
2021
 
   (unaudited) 
Contingent consideration liability  $2,216   $(398)  $375   $      -   $(57)  $2,136 
                               
Underwriters Warrants   21    -    -    -    137    158 
   $2,237   $(398)  $375   $-   $80   $2,294 

 

               Cancellation   Adjustment     
              

of Obligation/

  

to Fair Value/

     
   December 31,
2019
   Payments   Accretion  

Conversions

Exercises

  

Mark to

Market

   December 31,
2020
 
                         
Asuragen  $2,893   $(737)  $549   $                -   $(489)  $2,216 
                               
Underwriters Warrants   82    -    -    -    (61)   21 
   $2,975   $(737)  $549   $-   $(550)  $2,237